[email protected] +1 646 480 7505 (U.S.) | +44 203 318 2846 (U.K.)


Understand the influence of COVID-19 on the Active Implantable Medical Devices Market with our analysts monitoring the situation across the globe.

Global Statistics Representing Active Implantable Medical Devices Market Scenario

Rising elderly population, growing prevelance of cardiovascular diseaes and increasing global burden on ecnomies are propelling the active implantable medical devices market. As per WHO, around 17.9 million people die every year from CVDs, which accounts for 31% of all deaths globally. In addition, increasing cases of neurological disorders such as Parkinson’s disease, epilepsy, and dystopia is observed to be high in emerging economies such as India. Neurostimulation is an effective treatment for these neurological diseases. As per Global Burden of Disease report, rate of cases per 100,000 people has increased in Parkinson's by 15.7 percent, Alzheimer's 2.4 percent, and brain and nervous system cancers 8.9 percent.

New products are being launched to meet the demand of consumers by market players. For instance, in 2016 , Medtronic launched  first leadless pacemaker Micra TPS. Introduction of wireless technology and mobile connectivity has enhanced the effectiveness of these devices. In the same year, Boston Scientific Corporation launched the Precision Montage MRI Spinal Cord Stimulator (SCS) System, which gives access to full body magnetic resonance imaging (MRI) in a 1.5 Tesla environment.For instance, in 2017, Cochlear collaborated with Apple to provide cochlear implants with iPhone connectivity. 

Global active implantable medical devices market accounted for over USD 17,271.5 million in 2017 and is expected to grow at a CAGR of 5.9% during the forecast period, 2019–2026.

Intended Audience

  • Active Implantable Medical Devices Manufacturers
  • Potential Investors
  • Research and Development Institutes
  • Hospitals, Doctors, and Suppliers of Active Implantable Medical Devices

 Segmental Insights

Global active implantable medical devices market is segmented by product and end user.

By product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators and implantable hearing devices. The implantable cardioverter defibrillators segment is expected to grow at the fastest CAGR. The growth can be attributed to increasing incidence of cardiovascular diseases, technologically advanced devices and increasing demand for these devices in developing countries. Implantable cardioverter defibrillators are further segmented into single chamber, dual chamber, and biventricular pacemaker devices.

Based on end user, the market is segmented into hospitals, ambulatory surgery centers and specialty clinics. Rising investments and improving healthcare infrastructure is contributing in the hospital sector to emerge as the most prominent end user in the years to come.

Regional Insights

Geographically, the global active implantable medical devices market is segmented into four regions: North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).

North America is likely to dominate the active implantable medical devices market due to increasing geriatric population, rising prevalence of cardiovascular and neurological diseases, accessibility to advanced technologies, and increasing healthcare expenditure in the region. As per Disease Control and Prevention (CDC), 2017, around 2.7 to 6.1 million people in were suffering from atrial fibrillation, the most common type of heart arrhythmia in the U.S.

Europe is likely to emerge as the second largest active implantable medical devices market globally. This can be attributed to increasing incidences of chronic disease and reimbursement policy for implantation of pacemakers to reduce the financial burden. According to world’s export data, in 2017, European countries exported highest number of heart pacemakers during with the worth around USD 5 billion or 91.3% of the global total.

Asia pacific active implantable medical devices market is expected to witness significant growth on account of high prevalance of chronic diseases, aging population, healthcare reforms for infrastructural development, growing and less stringent regulations for new product development. As per the study conducted by The Global Burden of Disease, CVD death rate was 272 per 1,00000 individuals in India higher than the global average of 235.

LAMEA is expected to witness steady growth. Latin America is most affected by heart disease and it has put an economic burden of around USD 30.9 billion in 2015 and approximately 89.6 million people are diagnosed with the condition in the region.

Key Players:

Some of the key players in the global active implantable medical devices market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Livanova PLC, Nurotron Biotechnology Co. Ltd., Biotronik Se & Co., Kg, William Demant Holding A/S, Cochlear Limited and Sonova Holding AG.

 Active Implantable Medical Devices Market Segmentation

Active Implantable Medical Devices Market By Product

  • Implantable Cardioverter Defibrillators
  • Transvenous Implantable Cardioverter Defibrillators
    • Biventricular Implantable Cardioverter Defibrillators
    • Dual-Chamber Implantable Cardioverter Defibrillators
    • Single-Chamber Implantable Cardioverter Defibrillators
  • Subcutaneous Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulators
  • Implantable Hearing Devices
  • Active Hearing Implants
  • Passive Hearing Implants

Active Implantable Medical Devices Market By End User

  • Hospitals
  • Ambulatory Surgery Center
  • Specialty Clinics

Active Implantable Medical Devices Market Regions Covered:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Why buy this report?

  • Historical inferences, findings & analysis of the market from 2016 to 2018
  • Projections and performance forecast analysis for the future from 2019 to 2026
  • Production and consumption point of view (POV) analysis
  • Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
  • Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects

Request For Free Sample
Choose license Type

Buy Chapters or Sections

Avail customized purchase option to meet your exact research needs:

1)Buy sections of the report
2)Buy country level report
3)Request for historical data

Request a Free Sample   Special Pricing
Related Reports